Patents by Inventor Francois Leblond

Francois Leblond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230107538
    Abstract: The present application discloses a compound of formula (I) or a salt thereof: (I) and compositions comprising such compound or salt thereof. The use of such compound, salt thereof or composition comprising same for treating anemia or leukopenia, fibrosis, cancer, hypertension and/or a metabolic condition in a subject is also disclosed.
    Type: Application
    Filed: December 18, 2020
    Publication date: April 6, 2023
    Inventors: LYNE GAGNON, FRANÇOIS LEBLOND, LILIANNE GEERTS, BOULOS ZACHARIE, CHRIS DOYLE, JULIEN MARTEL, JEAN-SIMON DUCEPPE, JEAN-ERIC LACOSTE, JEAN-FRANÇOIS THIBODEAU
  • Patent number: 9532962
    Abstract: Use of medium-chain length fatty acids such as capric acid, caprylic acid or lauric acid and their salts or mono- or di- or triglycerides as nephroprotection agents to protect against renal failure progression in chronic kidney diseases This includes the treatment of kidney diseases associated with nephrectomy, renal fibrosis, glomerular sclerosis and end-stage renal disease Also includes the protection of the kidney against cytotoxic agent used in chemotherapy or autoimmune diseases or transplantation Further includes the treatment of renal failure progression associated with hypertension, infarct, tumor, diabetes mellitus, autoimmunity or inflammation.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: January 3, 2017
    Assignee: PROMETIC PHARMA SMT LIMITED
    Inventors: Vincent Pichette, Francois Leblond, Mouna Lagraoui, Lyne Gagnon
  • Publication number: 20100286269
    Abstract: Use of medium-chain length fatty acids such as capric acid, caprylic acid or lauric acid and their salts or mono- or di- or triglycerides as nephroprotection agents to protect against renal failure progression in chronic kidney diseases This includes the treatment of kidney diseases associated with nephrectomy, renal fibrosis, glomerular scelrosis and end-stage renal disease Also includes the protection of the kidney against cytotoxic agent used in chemotherapy or autoimmune diseases or transplantation Further includes the treatment of renal failure progression associated with hypertension, infarct, tumour, diabetes mellitus, autoimmunity or inflammation.
    Type: Application
    Filed: November 3, 2008
    Publication date: November 11, 2010
    Applicant: Prometic Biosciences Inc.
    Inventors: Vincent Pichette, Francois Leblond, Mouna Lagraoui, Lyne Gagnon
  • Patent number: 7128931
    Abstract: The present invention relates to semi-permeable microcapsules, which exhibit an increased resistance to mechanical stresses as well as an increased resistance to chemical degradation. More specifically, this semi-permeable microcapsule has a bead enclosing a material such as living cells, covalently linked to a semi-permeable layer, made of a polycation cross-linking derivative, covering the bead. The present invention is also directed to a pharmaceutical composition comprising the above-mentioned semi-permeable microcapsules. The present invention is also directed to the use of such microcapsule in a method for microencapsulating a beaded material and in a method for treating diabetes in a subject.
    Type: Grant
    Filed: October 17, 2003
    Date of Patent: October 31, 2006
    Inventors: Francois Leblond, Jean-Pierre Halle
  • Publication number: 20050147594
    Abstract: The present invention relates to semi-permeable microcapsules, which exhibit an increased resistance to mechanical stresses as well as an increased resistance to chemical degradation. More specifically, this semi-permeable microcapsule has a bead enclosing a material such as living cells, covalently linked to a semi-permeable layer, made of a polycation cross-linking derivative, covering the bead. The present invention is also directed to a pharmaceutical composition comprising the above-mentioned semi-permeable microcapsules. The present invention is also directed to the use of such microcapsule in a method for microencapsulating a beaded material and in a method for treating diabetes in a subject.
    Type: Application
    Filed: October 17, 2003
    Publication date: July 7, 2005
    Inventors: Francois Leblond, Jean-Pierre Halle